IBM, Oracle, Intel and IonQ join objections to OKXICE’s tokenized stock plan, bringing the reported total to 26 as SEC issuer-consent rules face scrutiny.
IBM, Oracle, Intel and IonQ join objections to OKXICE’s tokenized stock plan, bringing the reported total to 26 as SEC issuer-consent rules face scrutiny.